Home/ Supplements/ Kava/ Restal

Restal

product on market Capsule Indiana Botanic Gardens Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 60% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains kava, valerian, and hops, which have moderate evidence for reducing anxiety and improving sleep quality. Melatonin and lemon balm are also included to support sleep onset and relaxation. Overall, research for these combined botanical extracts is limited but generally supports their use for restlessness.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Restal
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
Other Combinations
Product Type
60%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Lemon Balm extract
80 mg
Hops extract
60 mg
Market median: 400.0mg (73 products) 15 studies (A:0, B:5)
2 mg
Market median: 3.0mg (984 products) 240 studies (A:2, B:109)
Market median: 300.0mg (214 products) 25 studies (A:0, B:6)

Other Ingredients

Rice Flour Gelatin Capsule Magnesium Stearate Maltodextrin Silicon Dioxide
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: Take 1 capsule daily, with a snack, at bedtime, as a dietary supplement, or as directed by a physician.

Warnings & Precautions

Caution: US FDA advises that a potential risk of rare, but severe, liver injury may be associated with kava-containing dietary supplements. Ask a healthcare professional before use if you have or have had liver problems, frequently use alcoholic beverages, or are taking any medication.

Ask a healthcare professional before use if you have or have had liver problems, frequently use alcoholic beverages, or are taking any medication.

Stop use and see a doctor if you develop symptoms that may signal liver problems (e.g., unexplained fatigue, abdominal pain, loss of appetite, fever, vomiting, dark urine, pale stools, yellow eyes or skin).

Not for use by persons under 18 years of age, or by pregnant or breastfeeding women.

Not for use by persons under 18 years of age, or by pregnant or breastfeeding women.

Not for use with alcoholic beverages. Excessive use, or use with products that cause drowsiness, may impair your ability to operate a vehicle or dangerous equipment.

For your protection, this container has an outer safety seal. (Do not accept if missing or broken.)

Keep out of reach of children

Additional Information

Nutritional sleep support

Store in a dry, cool place.

Metadata

Product Details

UPC / SKU7 03308 01065 7
DSLD Entry Date2017-08-22
Product TypeOther Combinations
FormCapsule
DSLD ID77353
Data Updated2026-04-11
Research

Research Evidence

19
Research Sources
48
Avg Quality
8
Rct
5
Systematic Review
4
Meta Analysis
2
Clinical Trial
B Kava extract for treating anxiety
Meta Analysis The Cochrane database of systematic reviews 2003 PubMed
B Kava for Generalized Anxiety Disorder: A Review of Current Evidence
Meta Analysis Journal of alternative and complementary medicine (New York, N.Y.) 2018 PubMed DOI
B Kava extract for treating anxiety
Systematic Review The Cochrane database of systematic reviews 2001 PubMed
B Kava extract for treating anxiety
Systematic Review The Cochrane database of systematic reviews 2002 PubMed
B The effectiveness and safety of Kava Kava for treating anxiety symptoms: A systematic review and analysis of randomized clinical trials
Systematic Review Complementary therapies in clinical practice 2018 PubMed DOI
C Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study
Rct The Australian and New Zealand journal of psychiatry 2020 PubMed DOI
C Kava and St. John's Wort: current evidence for use in mood and anxiety disorders
Systematic Review Journal of alternative and complementary medicine (New York, N.Y.) 2009 PubMed DOI
C Neuroimaging Insights: Kava's (Piper methysticum) Effect on Dorsal Anterior Cingulate Cortex GABA in Generalized Anxiety Disorder.
Rct Nutrients PubMed DOI
C The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava
Meta Analysis Annals of internal medicine 2002 PubMed
C Efficacy of kava extract for treating anxiety: systematic review and meta-analysis
Meta Analysis Journal of clinical psychopharmacology 2000 PubMed
View all evidence for Kava →
Compare

Similar Products

View all Kava products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.